Zhi-Qiang Wang
Overview
Explore the profile of Zhi-Qiang Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
502
Citations
5893
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lentivirus-mediated Knockdown of Ski Improves Neurological Function After Spinal Cord Injury in Rats
Wang Z, Ran R, Ma C, Zhao G, Zhou K, Zhang H
Neurochem Res
. 2024 Nov;
50(1):15.
PMID: 39549172
The glial scar that forms at the site of injury after spinal cord injury (SCI) is an important physical and biochemical barrier that prevents axonal regeneration and thus delays functional...
12.
Guo Z, Chen C, Szeto K, Taoufik M, Wang Z, Gong X
Small
. 2024 Oct;
20(52):e2406818.
PMID: 39420827
Tungsten-modified CeO is an excellent catalyst for the catalytic conversion of ammonia. However, the geometric and electronic properties of this catalyst and the detailed reaction mechanisms are not well understood....
13.
Zou X, Ding X, Feng Z, Ouyang Y, Li H, Wen K, et al.
Cell Rep Med
. 2024 Oct;
5(10):101779.
PMID: 39413735
Cisplatin is a cornerstone chemotherapy for nasopharyngeal carcinoma (NPC); however, certain patients are ineligible for cisplatin-based regimens. This phase 2 trial (NCT04405622) evaluated the efficacy and safety of gemcitabine and...
14.
Wang D, Liu X, He Q, Zheng F, Chen L, Zheng Y, et al.
CNS Neurosci Ther
. 2024 Oct;
30(10):e70065.
PMID: 39350328
Aims: Previous proteomics studies in dysferlinopathy muscle have been limited in scope, often utilizing 2D-electrophoresis and yielding only a small number of differential expression calls. To address this gap, this...
15.
Jin Y, Huang R, Guan W, Wang Z, Mai Z, Li Y, et al.
Signal Transduct Target Ther
. 2024 Sep;
9(1):227.
PMID: 39218995
Patients carrying mutations in polymerase epsilon/polymerase delta have shown positive responses to immune checkpoint inhibitors. Yet, prospective trials exploring the efficacy in those with polymerase epsilon/polymerase delta mutations are still...
16.
Zhang X, Wang Z, Gong X
Chem Sci
. 2024 Aug;
15(34):13717-13726.
PMID: 39211502
ZnO is an important catalytic material for CO/CO hydrogenation. In this work, the pristine ZnO(101̄0) and the surfaces with Zn-O dimer vacancies (ZnO(101̄0)-(Zn-O)) and oxygen vacancies are calculated. We find...
17.
Cheng Q, Wei H, Wang J, Wang Z, Gong X, Wang D
J Phys Chem Lett
. 2024 Aug;
15(34):8650-8659.
PMID: 39151150
This work systematically studied thermocatalytic and photocatalytic pathways of formaldehyde degradation and H-assisted O reduction over a Pt/anatase-TiO(101) composite via DFT calculations together with constrained molecular dynamics (MD) simulations. We...
18.
Wang Y, Wang S, Liao X, Wang Z, Li P, Yun T, et al.
World J Surg Oncol
. 2024 Jul;
22(1):189.
PMID: 39049011
Background: The aim of this study was to elucidate the histogenesis and genetic underpinnings of fibromatosis-like undifferentiated gastric carcinoma (FLUGC), a rare pathological entity. Method: Through a detailed analysis of...
19.
Xu C, Li X, Guo P, Yang K, Zhao Y, Chi H, et al.
ACS Appl Mater Interfaces
. 2024 Jul;
16(29):37927-37937.
PMID: 38980948
Fine tuning of the metal site coordination environment of a single-atom catalyst (SAC) to boost its catalytic activity for oxygen reduction reaction (ORR) is of significance but challenging. Herein, we...
20.
Zeng Y, Zuo D, Wang Z, Zhu J
Mov Disord
. 2024 Jul;
39(10):1894-1896.
PMID: 38965776
No abstract available.